has essential measure measures in guideline Blood Pressure Measurement Urine Test Gender Current Age History of Kidney Failure Diagnostic Instrument History of Type I and Type 2 Diabetes Diagnostic Instrument Kidney Function Test Urinary Albumin Test Label different from source's "Urinary Microalbumin - Assay" In the protocol provided, albumin concentration is measured according to a fluorescent immunoassay (FIA). The protocol also lists reference ranges for healthy adults. The criteria for clinically significant proteinuria have been changed from an albumin-creatinine ratio (ACR) of 30 mg/mmol or more to 3 mg/mmol or more. This is because there is evidence that the risk of adverse outcomes is a continuum and starts at an ACR well below 30 mg/mmol. The Sickle Cell Disease Research and Scientific Panel notes that the terms "microalbuminuria" and "macroalbuminuria" have been used clinically to describe different levels of abnormal albumin excretion rate: 30-299 mg/g urine creatinine, and >300 mg/gr urine creatinine, for microalbuminuria and macroalbuminuria, respectively. Recently, a new terminology has been proposed: "low level albuminuria" instead of microalbuminuia, and "high level albuminuria" for macroalbuminuria, since the older terminology could be interpreted as measuring different molecular forms of albumin. Because albuminuria may be affected by non-pathological factors (exercise, menstruation contamination, biological variability, etc.), abnormal values should be confirmed within 1-2 months. PhenX protocol: Urinary Microalbumin Assay #141501 Suggest update to label A bioassay to measure urine concentration of albumin, which is produced by the liver and is the most abundant protein in the blood. Urine Albumin Concentration Recommendations for the Management of Sickle Cell Disease in South Africa Standards for Clinical Care of Adults with Sickle Cell Disease in the UK